Ken Griffin Karuna Therapeutics, Inc. Transaction History

Citadel Advisors LLC

$509 Billion
Q1 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$161.01 - $317.85 $5.09 Million - $10 Million	-31,585 Reduced 16.66%	158,012 $50 Million
Q3 2023 Nov 14, 2023	BUY	$164.66 - $218.08 $15.6 Million - $20.7 Million	94,863 Added 100.14%	189,597 $32.1 Million
Q2 2023 Aug 14, 2023	BUY	$176.32 - $240.22 $16.7 Million - $22.8 Million	94,734 New	94,734 $20.5 Million
Q4 2022 Feb 14, 2023	SELL	$191.53 - $236.82 $10.7 Million - $13.2 Million	-55,673 Reduced 66.4%	28,168 $5.54 Million
Q3 2022 Nov 14, 2022	BUY	$123.79 - $277.42 $7.95 Million - $17.8 Million	64,222 Added 327.35%	83,841 $18.9 Million

Q2 2022 Aug 15, 2022	BUY	$93.97 - $143.33 $275,426 - $420,100	2,931 Added 17.56%	19,619 $2.48 Million
Q1 2022 May 16, 2022	BUY	$98.9 - $132.37 $921,055 - $1.23 Million	9,313 Added 126.28%	16,688 $2.12 Million
Q4 2021 Feb 14, 2022	SELL	$110.64 - $159.4 $449,862 - $648,120	-4,066 Reduced 35.54%	7,375 $966,000
Q3 2021 Nov 15, 2021	BUY	$101.2 - $125.87 $974,454 - $1.21 Million	9,629 Added 531.4%	11,441 $1.4 Million
Q2 2021 Aug 16, 2021	SELL	$107.45 - $135.95 $2.62 Million - $3.32 Million	-24,424 Reduced 93.09%	1,812 $206,000
Q4 2020 Feb 16, 2021	BUY	$75.23 - $109.23 $1.3 Million - $1.88 Million	17,226 Added 191.19%	26,236 $2.67 Million
Q3 2020 Nov 16, 2020	BUY	$71.31 - $109.74 $113,739 - $175,035	1,595 Added 21.51%	9,010 $696,000
Q2 2020 Aug 14, 2020	SELL	$62.14 - $117.21 $4.74 Million - $8.95 Million	-76,336 Reduced 91.15%	7,415 $826,000
Q1 2020 May 15, 2020	BUY	$60.41 - $115.92 $4.78 Million - $9.17 Million	79,099 Added 1700.32%	83,751 $6.03 Million
Q4 2019 Feb 14, 2020	SELL	$11.44 - $123.99 $843,368 - $9.14 Million	-73,721 Reduced 94.06%	4,652 $351,000
Q3 2019 Nov 14, 2019	SELL	$16.05 - $27.35 $764,381 - $1.3 Million	-47,625 Reduced 37.8%	78,373 $1.28 Million
Q2 2019 Aug 14, 2019	BUY	$20.02 - $20.02 $2.52 Million - $2.52 Million	125,998 New	125,998 $2.52 Million

Others Institutions Holding KRTX

# of Institutions

Shares Held

346K

Call Options Held

Put Options Held

View Full List

About Karuna Therapeutics, Inc.

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

More about KRTX

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account